about
Human monoclonal antibody-based therapy in the treatment of invasive candidiasisMapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display librariesNonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.Probing the natural antibody repertoire by combinatorial cloning of IgM and IgD isotypes in phage display vectors.Biomimetic antimicrobial cloak by graphene-oxide agar hydrogel.Synthesis and characterization of different immunogenic viral nanoconstructs from rotavirus VP6 inner capsid protein.Analysis of heat-induced changes in protein expression of Stenotrophomonas maltophilia K279a reveals a role for GroEL in the host-temperature adaptation.The Enterococcus faecalis virulence factor ElrA interacts with the human Four-and-a-Half LIM Domains Protein 2The PavA-like fibronectin-binding protein of Enterococcus faecalis, EfbA, is important for virulence in a mouse model of ascending urinary tract infection.The polyamine N-acetyltransferase-like enzyme PmvE plays a role in the virulence of Enterococcus faecalis.Production and characterization of a human recombinant monoclonal Fab fragment specific for influenza A viruses.Overexpression of Enterococcus faecalis elr operon protects from phagocytosisIn vitro interaction between alginate lyase and amphotericin B against Aspergillus fumigatus biofilm determined by different methods.Characterization of a Schistosoma mansoni cDNA encoding a B-like cyclophilin and its expression in Escherichia coli.Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients.Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells.Epicardial adipose tissue microbial colonization and inflammasome activation in acute coronary syndrome.Increased production of gliotoxin is related to the formation of biofilm by Aspergillus fumigatus: an immunological approach.Helicobacter pylori infection contributes to placental impairment in preeclampsia: basic and clinical evidences.Biological Characterization and in Vivo Assessment of the Activity of a New Synthetic Macrocyclic Antifungal Compound.Different effects of matrix degrading enzymes towards biofilms formed by E. faecalis and E. faecium clinical isolates.Liposomes loaded with bioactive lipids enhance antibacterial innate immunity irrespective of drug resistance.In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm.Serum Endotoxin Activity Measured with Endotoxin Activity Assay Is Associated with Serum Interleukin-6 Levels in Patients on Chronic Hemodialysis.Bacteria Meet Graphene: Modulation of Graphene Oxide Nanosheet Interaction with Human Pathogens for Effective Antimicrobial TherapyEffect of Alginate Lyase on Biofilm-GrownHelicobacter pyloriProbed by Atomic Force MicroscopyA fast and quantitative evaluation of the Aspergillus fumigatus biofilm adhesion properties by means of digital pulsed force modeDetection of Biofilm-Grown Aspergillus fumigatus by Means of Atomic Force Spectroscopy: Ultrastructural Effects of Alginate LyaseLiposome-based sensor for the detection of bacteriaReduction and shaping of graphene-oxide by laser-printing for controlled bone tissue regeneration and bacterial killing
P50
Q26864291-B0643823-E19E-483C-896C-00B3A710A728Q27469875-81EAA6FE-FE27-4AE8-8755-70D0CB98AD3EQ30711927-02778FC5-4A22-4DDC-B99B-FD595E270768Q31939267-EC3B4960-6D74-4DDF-9B28-6065A8BC57CDQ33685059-5C612885-ACDD-490F-9B93-0B124675244DQ33720570-FA91AECB-E08E-4043-A7AD-B3CDD8FAA172Q33757175-17F7D55D-D06D-4AB7-8018-534307DF1AFDQ33870920-74A14EC9-3A5F-433C-8FBD-A47E9DF4C89BQ34640209-C264FC68-9412-4851-945F-455EB8CFA080Q34889985-44267684-CF7D-42EA-96D3-1C709A116CB2Q35140153-2E6432E4-02C7-480F-B875-FA80E6B60758Q35640045-9EAA589E-84A7-445D-A11D-1C96D4E57AD9Q36667135-BB15D4DE-4B80-4F64-8511-A7D5BDEA46A2Q36809032-A505839F-D747-40AB-9682-5F0957CAB38DQ36904981-3602C414-6110-4D3C-9BBF-87F176F18145Q37378692-3C5E398E-CCF9-4928-BABF-5A689891A720Q38697472-EB583FD6-B4E8-4DD3-BE5C-7052B6341FF2Q38924564-5D556617-1A07-461F-AD6A-C38BB7CF6DF3Q39016052-FC415D7E-1E60-4E72-AD62-5C53CA5CAEACQ39532836-EA304D0B-463D-4C53-9203-AD1833C0E4F0Q39862754-2237E491-F8B8-477A-9721-5FB178FCC8D1Q40131825-CFB7F2DB-9089-443B-B73E-3A19E4AF3C79Q40277572-0D28A85A-B003-4982-9E98-39C4867B3539Q47712072-2BDB96BF-DB8A-4863-B26C-22C3C0EB3E83Q51541725-FB6E9B1D-A925-4D8A-932B-3DD808A78C7BQ58452843-EA9B5818-6FE4-4245-ADCE-26CAF0C8E7F5Q58452953-9BCB91C1-4B8E-46DD-AF4A-164C2055E3B6Q58453066-A92392E9-9783-42DC-9C76-F784D1F73CAEQ58453129-35E006D9-B71C-49CA-AE7A-69D48CC09460Q64128303-FDC38E5A-AE5E-41CA-A85F-EFD80DD93116Q64128331-4E22D359-46DB-4826-BF05-17A6BDCD4923
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francesca Bugli
@ast
Francesca Bugli
@en
Francesca Bugli
@es
Francesca Bugli
@nl
type
label
Francesca Bugli
@ast
Francesca Bugli
@en
Francesca Bugli
@es
Francesca Bugli
@nl
prefLabel
Francesca Bugli
@ast
Francesca Bugli
@en
Francesca Bugli
@es
Francesca Bugli
@nl
P106
P1153
6602926802
P21
P31
P496
0000-0001-9038-3233